Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?

Ann Hepatol. 2024 Jan-Feb;29(1):101153. doi: 10.1016/j.aohep.2023.101153. Epub 2023 Sep 19.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers with a high mortality rate. HCC development is associated with its underlying etiologies, mostly caused by infection of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV), alcohol, non-alcoholic fatty liver disease, and exposure to aflatoxins. These variables, together with human genetic susceptibility, contribute to HCC molecular heterogeneity, including at the cellular level. HCC initiation, tumor recurrence, and drug resistance rates have been attributed to the presence of liver cancer stem cells (CSC). This review summarizes available data regarding whether various HCC etiologies may be associated to the appearance of CSC biomarkers. It also described the genetic variations of tumoral tissues obtained from Western and Eastern populations, in particular to the oncogenic effect of HBV in the human genome.

Keywords: Biomarkers; Cancer stem cells; Etiology; Hepatocellular carcinoma; Stem cells.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / genetics
  • Carcinoma, Hepatocellular* / pathology
  • Hepatitis B virus / genetics
  • Hepatitis B* / complications
  • Hepatitis B, Chronic* / complications
  • Hepatitis C* / complications
  • Hepatitis C* / epidemiology
  • Humans
  • Liver Neoplasms* / genetics
  • Liver Neoplasms* / pathology
  • Neoplasm Recurrence, Local